Temple Hollowing on GLP‑1s: New Restylane Contour FDA Approval
March 23, 2026
Temple hollowing has become a hallmark of “Ozempic face” in GLP‑1 patients, often making people look older even as their health improves. This article explains how Restylane Contour’s new FDA approval for temple hollowing fits into safe, staged treatment planning for this rapidly growing patient group.